Biogen (NASDAQ:BIIB) Updates FY 2026 Earnings GuidanceMarket Beat·Jul 29 at 06:26 AMAPLS0.00%BIIB-0.87%
Biogen Q2 FY26 GAAP diluted EPS drops 85% to $0.66; revenue rises 3% to $2.74 billionPUBT·Jul 29 at 05:00 AMBIIB-0.87%APLS0.00%
Biogen: Key Takeaways From Needham’s Meeting With Top Managementbenzinga_article·Jun 29 at 10:27 AMBIIB-0.87%APLS0.00%
Biogen trims Apellis pipeline and R&D team after $5.6bn takeoverPharmaceutical Technology·Jun 29 at 05:42 AMBIIB-0.87%APLS0.00%
Biogen To Acquire RayThera For Up To $1 Billion, Expanding Immunology Pipelinebenzinga_article·Jun 18 at 10:07 AMBIIB-0.87%APLS0.00%
Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc. | BIIB Stock NewsStockTitan·Jun 17 at 09:59 AMBIIB-0.87%
Sobi to present new data on pegcetacoplan at ERA 2026PR Newswire·Jun 1 at 03:19 AMBIIB-0.87%APLS0.00%
Biogen Conference: Lupus, Kidney Programs Take Center Stage in Immunology PushMarket Beat·May 14 at 06:10 PMBIIB-0.87%APLS0.00%
